We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Automated Malaria Diagnosis Evaluated Using Autoanalyzer

By LabMedica International staff writers
Posted on 04 Feb 2019
Early and accurate diagnosis of malaria is a critical aspect of efforts to control the disease, and several diagnostic tools are available. More...
Microscopic assessment of a peripheral blood smear enables direct visualization of parasites in infected red blood cells and is the clinical diagnostic gold standard.

As the field of medical diagnostics continues to evolve, there is a constant search for alternative methods to detect and quantify malaria parasites. To reduce analytical time and improve accuracy, automation of the malaria diagnostic process is highly desirable. Automated hematology analyzers can offer fast, sensitive and cost-effective assessment of all suspected malaria cases.

Scientists at the University of the Witwatersrand (Johannesburg, South Africa) and their colleagues analyzed blood samples for malaria by different methods. Thin peripheral blood smears were prepared and evaluated by routine laboratory staff. The MAKROmed malaria rapid test kit, which detects the Plasmodium falciparum-specific HRP2 antigen, and the SureTest MAL malaria antigen test kit, which detects both P. falciparum and P. vivax species were used.

The team analyzed the samples using the automated Sysmex XN-30 analyzer and the prototype, XN-10 (M), which utilize fluorescence flow cytometry to directly detect and quantitate parasite-infected red blood cells. Both analyzers generate results automatically, which are presented as malaria-negative or malaria-positive, accompanied by a conventional FBC, MI-RBC#, MI-RBC%, an M scattergram and a flag with a suggested species classification, either as suspected P. falciparum or suspected ‘others’ (i.e. non-falciparum species).

The scientists reported the XN-30 correlated with microscopy and the analyzer demonstrated 100% sensitivity and specificity. Measurements were reproducible and storage of samples at room temperature did not affect the parameters. Several Plasmodium species were detected, including Plasmodium falciparum, Plasmodium vivax and Plasmodium ovale. The XN-30 also identified the transmissible gametocytes as a separate cluster on the scattergrams. Abnormal red blood cell indices (low hemoglobin and raised reticulocyte counts), hemoglobinopathies and thrombocytopenia did not interfere with the detection of parasites. The XN-30 also generated a concurrent full blood count for each sample. The XN-30 may serve as the ideal donor-screening tool in blood banks of malaria-endemic regions.

The authors concluded that the novel technology of the Sysmex XN-30 provides a robust, rapid, automated and accurate platform for diagnosing malaria in a clinical setting. The objective enumeration of red blood cells infected with Plasmodium species makes it suitable for global use and allows monitoring of the parasite load once therapy has been initiated, thereby providing an early marker of drug resistance. The study was published on January 22, 2019, in the Malaria Journal.

Related Links:
University of the Witwatersrand


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
Automatic Hematology Analyzer
LABAS F9000
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.